0 27 eps expected for presbia plc lens 3


$-0.27 EPS Expected for Presbia PLC (LENS)


March 29, 2018 – By Linda Rogers



Investors sentiment increased to 0.67 in 2017 Q4. Its up 0.27, from 0.4 in 2017Q3. It increased, as 2 investors sold Presbia PLC shares while 1 reduced holdings. 2 funds opened positions while 0 raised stakes. 2.65 million shares or 3.60% less from 2.75 million shares in 2017Q3 were reported.

Morgan Stanley stated it has 0% of its portfolio in Presbia PLC (NASDAQ:LENS). Fmr Ltd Liability Co has invested 0% in Presbia PLC (NASDAQ:LENS). Geode Cap Mgmt Ltd Liability Corporation holds 14,898 shares. Amundi Pioneer Asset Mngmt reported 0% in Presbia PLC (NASDAQ:LENS). Blackrock reported 2,007 shares. Royal Natl Bank Of Canada owns 2 shares or 0% of their US portfolio. 52,757 are owned by Vanguard.

Analysts expect Presbia PLC (NASDAQ:LENS) to report $-0.27 EPS on April, 4. The stock decreased 10.19% or $0.2578 during the last trading session, reaching $2.2722. About 12,535 shares traded. Presbia PLC (NASDAQ:LENS) has declined 17.32% since March 29, 2017 and is downtrending. It has underperformed by 28.87% the S&P500.

Presbia PLC (NASDAQ:LENS) Ratings Coverage

Among 3 analysts covering Presbia (NASDAQ:LENS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Presbia has $14 highest and $7.0 lowest target. $10.33’s average target is 354.63% above currents $2.2722 stock price. Presbia had 3 analyst reports since May 10, 2016 according to SRatingsIntel. The stock has “Buy” rating by Rodman & Renshaw on Tuesday, May 10. H.C. Wainwright maintained the shares of LENS in report on Wednesday, December 20 with “Buy” rating. The firm has “Buy” rating given on Thursday, October 5 by Jefferies.

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company has market cap of $38.90 million. The firm provides the refractive lens for patient surgeries, as well as accessories for procedures. It currently has negative earnings. It primarily operates in South Korea, Australia, the Netherlands, Ireland, and Canada.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.





Back To Top